Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Belvedere, Raffaella ^a   Bizzarro, Valentina ^a   Popolo, Ada ^a   Dal Piaz, Fabrizio ^a   Vasaturo, Michele ^a   Picardi, Paola ^a   Parente, Luca ^a   Petrella, Antonello ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Annexin A1; Cell invasion; Cell migration; Formyl peptide receptors; Pancreatic cancer

Indexed keywords

FORMYLPEPTIDE RECEPTOR; LIPOCORTIN 1; MATRIGEL; MIMETIC PEPTIDE; PEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANNEXIN A1 PEPTIDE (2-26); FPR1 PROTEIN, HUMAN; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOMA CELL; CARCINOMA CELL LINE; CELL INVASION; CELL INVASION ASSAY; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; METASTASIS; PANCREAS CARCINOMA; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SUPERNATANT; WESTERN BLOTTING; WOUND HEALING; CELL MOTION; CYTOPLASM; GENE SILENCING; METABOLISM; PANCREAS TUMOR; PATHOLOGY; SECRETION (PROCESS); TUMOR CELL LINE; TUMOR INVASION;

ANNEXIN A1; CELL LINE, TUMOR; CELL MOVEMENT; CYTOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PEPTIDES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 84925439444     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-961     Document Type: Article

References (57)

1. Jemal A, Siegel R, Xu J, Ward E Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
2. Bardeesy N, DePinho RA Pancreatic cancer biology and genetics. Nat Rev Cancer 2002, 2:897-909.
3. Komoto M, Nakata B, Nishii T, Kawajiri H, Shinto O, Amano R, Yamada N, Yashiro M, Hirakawa K In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer. Cancer Sci 2010, 101:468-473.
4. Winter JM, Yeo CJ, Brody JR Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol 2013, 107:15-22.
5. Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, Zheng H, Szymonifka J, Wargo JA, Thayer SP, Lauwers GY, Deshpande V, Mino-Kenudson M, Fernàndez-del Castillo C, Lillemoe KD, Warshaw AL Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 2012, 152:S43-S49.
6. Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H Invasion and metastasis in pancreatic cancer. Mol Cancer 2003, 2:14.
7. Lim LHK, Pervaiz S Annexin 1: the new face of an old molecule. FASEB J 2007, 21:968-975.
8. Fatimathas L, Moss SE Annexins as disease modifiers. Histol Histopathol 2010, 25:527-532.
9. Guo C, Liu S, Sun MZ Potential role of Anxa1 in cancer. Future Oncol 2013, 9:1773-1793.
10. Boudhraa Z, Rondepierre F, Ouchchane L, Kintossou R, Trzeciakiewicz A, Franck F, Kanitakis J, Labeille B, Joubert-Zakeyh J, Bouchon B, Perrot JL, Mansard S, Papon J, Dechelotte P, Chezal JM, Miot-Noirault E, Bonnet M, D'Incan M, Degoul F Annexin A1 in primary tumors promotes melanoma dissemination. Clin Exp Metastasis 2014, [Epub ahead of print] doi:10.1007/s10585-014-9665-2.
11. Bizzarro V, Fontanella B, Franceschelli S, Pirozzi M, Christian H, Parente L, Petrella A Role of Annexin A1 in mouse myoblast cell differentiation. J Cell Physiol 2010, 224:757-765.
12. Bizzarro V, Belvedere R, Dal Piaz F, Parente L, Petrella A Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors. PLoS One 2012, 7:e48246.
13. Bizzarro V, Fontanella B, Carratù A, Belvedere R, Marfella R, Parente L, Petrella A Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. PLoS One 2012, 7:e45639.
14. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P, van de Water B Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 2011, 107:6340-6345.
15. Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT, Kuo ML Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer 2012, 118:5757-5767.
16. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009, 61:119-161.
17. Huang J, Chen K, Chen J, Gong W, Dunlop NM, Howard OM, Gao Y, Bian XW, Wang JM The G-protein coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells. Br J Cancer 2010, 102:1052-1060.
18. Huang J, Chen K, Gong W, Dunlop NM, Wang JM G-protein coupled chemoattractant receptors and cancer. Front Biosci 2008, 13:3352-3363.
19. Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wuang JM Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 2005, 97:823-835.
20. Yang Y, Liu Y, Yao X, Ping Y, Jiang T, Liu Q, Xu S, Huang J, Mou H, Gong W, Chen K, Bian X, Wang JM Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol 2011, 179:1504-1512.
21. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, Nusrat A Annexin I regulates SKCO-15 cell invasion by signaling through Formyl Peptide Receptors. J Biol Chem 2006, 28:19588-19599.
22. de Coupade C, Solito E, Levine JD Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol 2003, 140:133-145.
23. Dal Piaz F, Cotugno R, Lepore L, Vassallo A, Malafronte N, Lauro G, Bifulco G, Belisario MA, De Tommasi N Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells. J Proteomics 2013, 82:14-26.
24. Montinaro A, Forte G, Sorrentino R, Luciano A, Palma G, Arra C, Adcock IM, Pinto A, Morello S Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in mice. PLoS One 2012, 7:e45401.
25. Adesso S, Popolo A, Bianco G, Sorrentino R, Pinto A, Autore G, Marzocco S The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS One 2013, 8:e76778.
26. Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010, 39:425-435.
27. Thiery JP Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746.
28. Huber MA, Kraut N, Beug H Molecular requirements for epithelial mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558.
29. Salnikov AV, Liu L, Platen M, Gladkich J, Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J, Schemmer P, Büchler MW, Herr I Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 2012, 7:e46391.
30. Bergman A, Condeelis JS, Gligorijevic B Invadopodia in context. Cell Adh Migr 2014, 8. [Epub ahead of print] doi:10.4161/cam.28349.
31. Li S, Guan JL, Chien S Biochemistry and biomechanics of cell motility. Annu Rev Plant Physiol Plant Mol Biol 2005, 7:105-150.
32. Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ, Buckingham JC Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J 2006, 20:1498-1500.
33. Hullin F, Raynal P, Ragab-Thomas JM, Fauvel J, Chap H Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis. J Biol Chem 1989, 264:3506-3513.
34. Ambrose MP, Hunninghake GW Corticosteroids increase lipocortin I in alveolar epithelial cells. Am J Respir Cell Mol Biol 1990, 3:349-353.
35. Croxtall JD, Choudhury Q, Newman S, Flower RJ Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation. Biochem Pharmacol 1996, 52:351-356.
36. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, et al Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996, 2:1259-1262.
37. Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 2000, 267:3220-3225.
38. Sampey AV, Hutchinson P, Morand EF Annexin I surface binding sites and their regulation on human fibroblast-like synoviocytes. Arthritis Rheum 2000, 43:2537-2542.
39. Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B, Zhou LP, Liu F, Zhang JS, Wang K, Xie YQ, Shao YF, Zhao XH Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004, 10:1466-1470.
40. Chen CY, Shen JQ, Wang F, Wan R, Wang XP Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma. Asian Pac J Cancer Prev 2012, 13:4707-4712.
41. Coppola D Molecular prognostic markers in pancreatic cancer. Cancer Control 2000, 7:421-427.
42. Liu K, Qin CK, Wang ZY, Liu SX, Cui XP, Zhang DY Expression of tumour necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels. Asian Pac J Cancer Prev 2012, 13:847-850.
43. Haigler HT, Schlaepfer DD Annexin I phosphorylation and secretion. In The Annexins. Edited by Moss SE. London; Portland Press; 1992:11-34.
44. Rescher U, Danielczyk A, Markoff A, Gerke V Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 2002, 169:1500-1504.
45. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003, 101:4140-4147.
46. Solito E, Raugei G, Melli M, Parente L Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett 1991, 291:238-244.
47. Côtè MC, Lavoie JR, Houle F, Poirier A, Rousseau S, Huot J Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM Kinase 1-mediated phosphorylation of Annexin 1. J Biol Chem 2010, 285:8013-8021.
48. Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP, Kuo MY Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 2008, 97:544-550.
49. Zhu F, Xu C, Jiang Z, Jin M, Wang L, Zeng S, Teng L, Cao J Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat Rec (Hoboken) 2010, 293:1310-1314.
50. Han G, Tian Y, Duan B, Sheng H, Gao H, Huang J Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014, 7:751-759.
51. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002, 19:319-326.
52. Pepinsky RB, Sinclair LK Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986, 321:81-84.
53. Kwon JH, Lee JH, Kim KS, Chung YW, Kim IY Regulation of cytosolic phospholipase A2 phosphorylation by proteolytic cleavage of annexin A1 in activated mast cells. J Immunol 2012, 188:5665-5673.
54. Takada M, Nakamura Y, Koizumi T, Toyama H, Kamigaki T, Suzuki Y, Takeyama Y, Kuroda Y Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 2002, 25:45-48.
55. Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer 2001, 93:204-211.
56. Perretti M, D'Acquisto F Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009, 9:62-70.
57. Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, Hilgarth RS, Kundu K, Murthy N, Kusters D, Reutelingsperger C, Perretti M, Parkos CA, Neish AS, Nusrat A Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 2013, 123:443-454.